2007
DOI: 10.1089/cap.2007.0006
|View full text |Cite
|
Sign up to set email alerts
|

Psychotherapeutic Medication Prevalence in Medicaid-Insured Preschoolers

Abstract: Preschool psychotherapeutic medication use increased across ages 2 to 4 for stimulants, antipsychotics, and antidepressants, reflecting use for psychiatric/behavioral disorders. However, the use of anxiolytic/sedative/hypnotics and anticonvulsants was more stable across these years, suggesting medical usage. Additional research to assess the benefits and risks of psychotherapeutic drugs is needed, particularly when such usage is off-label for both psychiatric and nonpsychiatric conditions.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
45
2
2

Year Published

2008
2008
2017
2017

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 98 publications
(52 citation statements)
references
References 28 publications
3
45
2
2
Order By: Relevance
“…However, during the sample period, more information became available on the negative health effects of some second-generation antipsychotic medications, leading the FDA in 2003 to issue a warning regarding the risk of hyperglycemia and diabetes mellitus based on several studies which were published during our study period (31). In addition, the remarkable increases in the rates of use for off-label conditions and use in children (5,19,25,32,33) may lead to lower dosing.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…However, during the sample period, more information became available on the negative health effects of some second-generation antipsychotic medications, leading the FDA in 2003 to issue a warning regarding the risk of hyperglycemia and diabetes mellitus based on several studies which were published during our study period (31). In addition, the remarkable increases in the rates of use for off-label conditions and use in children (5,19,25,32,33) may lead to lower dosing.…”
Section: Discussionmentioning
confidence: 99%
“…It is unknown which is driving the current growth in antipsychotic medications, although one recent study using MEPS data notes that just over a third of the increase in the larger class of psychotropic medication was due to new users whereas twothirds of the increase was due to greater spending per user (6). In addition, much of our knowledge about antipsychotic medication use comes from Medicaid populations (2,19) with little information available on trends in the use of antipsychotics from privately insured and uninsured populations.…”
Section: Introductionmentioning
confidence: 99%
“…In the United States, the prevalence of children with behavioral problems has increased markedly in the last 15 years (Buitelaar et al, 2006;Cooper et al, 2006;Egger & Angold, 2006;Zito et al, 2003;Zito et al, 2008). Prescriptions for psychotherapeutic medications directed toward reducing behavioral problems in the school aged child increased two to three fold in the early 1990"s (Zito et al, 2007) and from the mid 1990"s to 2002 rates for these medications increased from 8.6 per 1000 children to 39.4 per 1000 children (Cooper et al, 2006).…”
Section: Significance Of the Problemmentioning
confidence: 99%
“…Preschool children also had marked increases in psychotropic medication usage as estimates now indicate 2.3% to 7% of preschoolers receive one or more prescriptions for these medications (Luby, Stalets, & Belden, 2007;Raghavan et al, 2005;Zito et al, 2007). In the 2007 National Survey of Children"s Health, 40% of parents of preschool children had concerns about their child"s physical, social, and emotional development and 17.5% of the preschooler"s parents had concerns with how well their child got along with other preschoolers (CAHMI, 2007).…”
Section: Significance Of the Problemmentioning
confidence: 99%
See 1 more Smart Citation